Conference Learning Objectives

By the end of the conference, participants will be able to:

1. Apply pharmacogenomic testing to patient cases and choose an appropriate clinical action.

2. Explain the data that supports return on investment of pharmacogenomics implementation and testing.

3. Recognize the challenges related to assessing return on investment and cost savings of pharmacogenomics.

4. Describe the costs of implementing pharmacogenomics and resources needed.

5. Understand the role of pharmacogenomics in improving quality of care and adverse drug reaction reduction.

6. Review the importance and decision process for selecting clinical decision support for pharmacogenomics.

7. Describe best practices for return of pharmacogenomics results and education to patients.

8. Envision how pharmacoeconomic strategies could be applied in your practice for pharmacogenomics.

9. Understand a payer’s perspective on pharmacogenomics.

10. Explain CMS local coverage determinations and the role they play in pharmacogenomics.

11. Be able to apply the new and updated pharmacogenomics practice guidelines.

12. Understand the difficulties in assessing multigene pharmacogenomic associations. 

13. Recognize the considerations in establishing a pharmacogenomics telehealth and medication therapy management program.

14. Describe novel education and implementation strategies used to facilitate pharmacogenomics in healthcare organizations.

15. Understand the changing regulatory landscape of pharmacogenomics and the potential implications.

16. Describe implementation of pharmacogenomics in rural and underserved populations, and recognize the important considerations in minority populations.